Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats

被引:0
|
作者
JIN Ming [1 ]
WANG Lin [1 ]
WU Yan [1 ]
ZANG Bao-xia [1 ]
TAN Li [1 ]
机构
[1] Department of Pharmacology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital,Capital Medical University
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-κB p65; α-smooth muscle actin; Chinese medicine;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
摘要
Objective: To observe the effect of hydroxysafflor yellow A(HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflammation and pulmonary fibrosis induced by bleomycin(BLM) in rats. Methods: Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone(DXM) group. Three doses of HSYA(35.6, 53.3, and 80.0 mg·kg;·day;) were intraperitoneally(i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control(n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor(TNF)-α, interleukin(IL)-1β, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-κB p65 or α-smooth muscle actin(α-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. Results: On the 7 th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure(PaO;) increased(HSYA 80.0 mg·kg;, P<0.01) and CO;partial pressure(PaCO;) decreased(HSYA 53.3, 80.0 mg·kg;, P<0.05). Moreover, the mRNA expression of TNF-α, IL-1β, and IL-6; and the number of NF-κB p65 positive cells was lower in HSYA 53.3 and 80.0 mg·kg;groups than those in the model group(all P<0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO;(HSYA 53.3, 80.0 mg·kg;, P<0.01), and decreased PaCO;(53.3 and 80.0 mg·kg;, P<0.05). Further, the mRNA expression of TGF-β1, α-SMA, and collagen Ⅰ as well as the number of α-SMA positive cells increased in the model group and HSYA can attenuate these changes(53.3, 80.0 mg·kg;, P<0.05). Hematoxylin and eosin and Masson’s trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups(53.3, 80.0 mg·kg;, P<0.05). Conclusion: HSYA could alleviate acute lung inflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Parlakpinar, Hakan
    Taslidere, Elif
    Yildiz, Sedat
    Polat, Alaadin
    Vardi, Nigar
    Colak, Cemil
    Ermis, Hilal
    INFLAMMATION, 2015, 38 (03) : 1166 - 1180
  • [22] Protective and Therapeutic Effect of Molsidomine on Bleomycin-Induced Lung Fibrosis in Rats
    Talat Kilic
    Hakan Parlakpinar
    Alaadin Polat
    Elif Taslidere
    Nigar Vardi
    Ediz Sarihan
    Hilal Ermis
    Kevser Tanbag
    Inflammation, 2014, 37 : 1167 - 1178
  • [23] Protective and Therapeutic Effect of Molsidomine on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Parlakpinar, Hakan
    Polat, Alaadin
    Taslidere, Elif
    Vardi, Nigar
    Sarihan, Ediz
    Ermis, Hilal
    Tanbag, Kevser
    INFLAMMATION, 2014, 37 (04) : 1167 - 1178
  • [24] Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats
    Talat Kilic
    Hakan Parlakpinar
    Elif Taslidere
    Sedat Yildiz
    Alaadin Polat
    Nigar Vardi
    Cemil Colak
    Hilal Ermis
    Inflammation, 2015, 38 : 1166 - 1180
  • [25] THE EFFECT OF LIPOPOLYSACCHARIDE ON BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    PHAN, SH
    FANTONE, JC
    MCGARRY, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 54 - 54
  • [26] PROTECTIVE AND THERAPEUTIC EFFECT OF FELODIPINE AGAINST BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    Tomomi, N.
    Tomoaki, I.
    Tanaka, K. I.
    RESPIROLOGY, 2016, 21 : 122 - 122
  • [27] Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
    Tanaka, Ken-ichiro
    Niino, Tomomi
    Ishihara, Tomoaki
    Takafuji, Ayaka
    Takayama, Takahiro
    Kanda, Yuki
    Sugizaki, Toshifumi
    Tamura, Fumiya
    Kurotsu, Shota
    Kawahara, Masahiro
    Mizushima, Tohru
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Emodin alleviates bleomycin-induced pulmonary fibrosis in rats
    Guan, Ruijuan
    Zhao, Xiaomei
    Wang, Xia
    Song, Nana
    Guo, Yuhong
    Yan, Xianxia
    Jiang, Liping
    Cheng, Wenjing
    Shen, Linlin
    TOXICOLOGY LETTERS, 2016, 262 : 161 - 172
  • [29] Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats
    Sogut, S
    Ozyurt, H
    Armutcu, F
    Kart, L
    Iraz, M
    Akyol, O
    Ozen, S
    Kaplan, S
    Temel, I
    Yildirim, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 213 - 220
  • [30] Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
    Yao, HW
    Zhu, JP
    Zhao, MH
    Lu, Y
    RESPIRATION, 2006, 73 (02) : 236 - 242